
Sharma Natraj Kannan
About Sharma Natraj Kannan
Data last updated:
Sharma Natraj Kannan is a Director at Renserv Global Private Limited (since 2025), Director at Symbio Generrics India Private Limited (since 2022) and Director at Renew Akshay Urja Limited (since 2018), and holds 1 more current directorship. The companies operate in Engineering, Pharma and Environment. The 3 current companies with reported revenue have a combined latest revenue of ₹1,349 Cr; the largest is Renserv Global Private Limited at ₹749 Cr (FY 2025). Earlier, Sharma Natraj Kannan was a Director at Solzen Urja Private Limited (2022–2023) and Additional Director at Positiveedge Technology Private Limited (2009) and 8 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Mar 2025 | 2019 | ₹749 Cr (FY 2025) | Active | |
| Director | 19 Sep 2022 | 2011 | ₹435 Cr (FY 2025) | Active | |
| Director | 29 Jan 2018 | 2015 | ₹165 Cr (FY 2025) | Active | |
| Partner | 08 Sep 2018 | 2011 | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jun 2022 | 2019 | ₹177 Cr (FY 2026) | Active | |
| Additional Director | 24 Oct 2009 | 2008 | ₹18.34 Cr (FY 2024) | Active | |
| Director | 28 Nov 2018 | 2012 | ₹81.53 Cr (FY 2025) | Active | |
| Director | 28 Nov 2018 | 2012 | ₹139 Cr (FY 2025) | Active | |
| Company Secretary | 08 May 2006 | 1990 | ₹5,009 Cr (FY 2026) | Active | |
| Director | 15 Feb 2017 | 2012 | ₹86.00 Cr (FY 2025) | Active | |
| Partner | 27 Nov 2013 | 2013 | Active | ||
| Director | 31 Mar 2006 | 2002 | Amalgamated | ||
| Director | 28 Sep 2007 | 2001 | Amalgamated | ||
| Director | 12 Mar 2008 | 2008 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sharma Natraj Kannan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sharma Natraj Kannan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sharma Natraj Kannan
Sharma Natraj Kannan currently holds 4 directorships: Renserv Global Private Limited (Director, since 31 Mar 2025, revenue ₹749 Cr (FY 2025)); Symbio Generrics India Private Limited (Director, since 19 Sep 2022, revenue ₹435 Cr (FY 2025)); Renew Akshay Urja Limited (Director, since 29 Jan 2018, revenue ₹165 Cr (FY 2025)); Maxximuz Partners Llp (Partner, since 08 Sep 2018).
Sharma Natraj Kannan was first appointed on 31 Mar 2006 as Director at Sequent Scientific Limited. The most recent appointment on record is 31 Mar 2025 at Renserv Global Private Limited.
The 3 current companies of Sharma Natraj Kannan that report revenue have a combined latest revenue of ₹1,349 Cr: Renserv Global Private Limited ₹749 Cr (FY 2025); Symbio Generrics India Private Limited ₹435 Cr (FY 2025); Renew Akshay Urja Limited ₹165 Cr (FY 2025).
Sharma Natraj Kannan held 10 earlier board appointments: Solzen Urja Private Limited (Director, 01 Jun 2022 to 01 Jun 2023); Positiveedge Technology Private Limited (Additional Director, 24 Oct 2009 to 25 Nov 2009); Renew Wind Energy (Ap) Private Limited (Director, 28 Nov 2018 to 15 Dec 2019); Renew Wind Energy (Karnataka) Private Limited (Director, 28 Nov 2018 to 15 Dec 2019); Strides Pharma Science Limited (Company Secretary, 08 May 2006 to 01 Jun 2010); and 5 more.
The current boards of Sharma Natraj Kannan's companies include Bharat Bahl (Renserv Global Private Limited), Priyanka Pahuja (Renserv Global Private Limited), Sonali Akash Gaurav (Renserv Global Private Limited), Varun Chugh (Renserv Global Private Limited), Akash Suresh Puranik (Symbio Generrics India Private Limited), Akash Suresh Puranik (Symbio Generrics India Private Limited), among others.